PMID 40538943

Research
All papers

Effects of high-intensity interval training on executive functions and IGF-1 levels in sedentary young women: a randomized controlled trial

Question

Does online HIIT, with or without an added daily-step goal, improve salivary IGF-1 and executive functions in sedentary young women compared with control?

Summary

This randomized trial tested 12 weeks of online HIIT, HIIT plus a 10,000-steps/day physical activity goal, or control in sedentary young women. The study did not find clear group-by-time effects showing that HIIT specifically improved salivary IGF-1 or executive function. Some cognitive scores improved over time, but the pattern was not specific to the intervention groups, so practice effects or outside factors remain plausible.

Methodology

  • Sedentary young women.
  • 77 participants.
  • Bodyweight/cardio online HIIT.
  • Work intervals: 30 s exercise.
  • Recovery: 30 s rest.
  • Intensity: RPE 8 progressing to 9-10 on CR10.
  • About 40 min.
  • 3 sessions/week.
  • 12 weeks.
  • Three-arm randomized controlled trial with blinded assessors/data analysts and 12-week follow-up after training stopped.
  • Salivary IGF-1, and Executive function were tracked.

Outcomes

IGF-1

No statistically significant group, time, or interaction effect for salivary IGF-1.

Reported p values > .40.

No clear change

Executive function

Some measures improved over time, but not with consistent group-by-time effects attributable to HIIT.

Digit Span Backward time p < .001 but interaction p = .286; Digit Span Total interaction p = .081.

Mixed

Insights

  • 30/30 online HIIT is implementable, but this trial does not justify strong cognition or IGF-1 claims.
  • Daily activity goals may be paired with structured HIIT, but evidence here is trend-level.

Limitations

  • Attrition from 77 to 58 analyzed.
  • Healthy young women only.
  • Practice effects in cognitive testing.
  • Surrogate biomarker outcome.
  • No detailed adverse-event reporting.
  • Online supervision and no objective neurobiological measures.

Safety

  • No adverse-event details were reported.